Medizinische Univeristät Graz
Graz, A-8036, Austria
NCT Number: NCT02371785
This study evaluates the performance of the CorPath 200 System to deliver guide wires and balloons to blockages in the arteries of the leg.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Graz, A-8036, Austria
The CorPath 200 System is currently marketed for remotely delivering guide wires, balloons and stents to blockages in the coronary arteries. This study will evaluate the feasibility of CorPath 200 System to deliver guide wires and balloons to blockages in non-coronary arteries.
Guide wires and balloons are delivered to blockages in the lower limbs manually by doctors.If this study shows that guide wires and balloons can be safely delivered to blockages in the lower limbs, then it will be an alternative for physicians.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Presence of superficial femoral artery and/or iliac stenosis (>50%) or occlusion of up to 50 mm in length as determined by angiogram prior to index interventional procedure.
Exclusion criteria
Remote delivery of guide wires and balloon catheters for use in percutaneous vascular interventions (PVI).
Time frame: Procedure
Number of lesions for which there was technical success" as accurate and appropriate.
Time frame: Procedure
No device-related serious adverse events during the procedure.
Time frame: 24-hours
Defined as <50% residual stenosis in all CorPath 200 System treated lesions at the completion of the interventional procedure (without an unplanned switch to the manual procedure) in the absence of device-related SAE, either within twenty-four (24) hours of the procedure or prior to hospital discharge, whichever occurs first.
Time frame: Procedure
As recorded by an X-ray system utilized during the procedure.
Time frame: Procedure
Total amount of contrast used during CorPath procedure.
Time frame: Procedure
Defined as the time measured from the insertion of the hemostasis sheath until procedure complete (guide catheter removed).
Time frame: Procedure
Defined as the time measured from the insertion of the guide catheter until the removal of the guide catheter.
Siemens Healthineers Endovascular Robotics, Inc.
Industry
Acronym: RAPID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04229563
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT03395236
Arterial Occlusive Diseases, Arteriosclerosis
Frankfurt, Germany
View Trial DetailsNCT02942966
Arterial Occlusive Diseases, Arteriosclerosis
Yuma, Arizona, United States
View Trial DetailsNCT02096757
Arterial Occlusive Diseases, Arteriosclerosis
San Francisco, California, United States
View Trial Details